The drug, branded Zusduri, will be the first to get approval to treat a type of bladder cancer that has not spread beyond the inner layers of the organ. The disease primarily affects older population. Read more: https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/fda-approves-urogens-breakthrough-bladder-cancer-treatment-zusduri/121814990